U.S. Physical Therapy Inc
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-relate… Read more
U.S. Physical Therapy Inc (UPH) - Net Assets
Latest net assets as of September 2025: €782.44 Million EUR
Based on the latest financial reports, U.S. Physical Therapy Inc (UPH) has net assets worth €782.44 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.20 Billion) and total liabilities (€413.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €782.44 Million |
| % of Total Assets | 65.41% |
| Annual Growth Rate | 15.83% |
| 5-Year Change | 173.4% |
| 10-Year Change | 247.73% |
| Growth Volatility | 19.4 |
U.S. Physical Therapy Inc - Net Assets Trend (2014–2024)
This chart illustrates how U.S. Physical Therapy Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for U.S. Physical Therapy Inc (2014–2024)
The table below shows the annual net assets of U.S. Physical Therapy Inc from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €759.05 Million | +16.38% |
| 2023-12-31 | €652.24 Million | +34.60% |
| 2022-12-31 | €484.57 Million | +63.05% |
| 2021-12-31 | €297.18 Million | +7.04% |
| 2020-12-31 | €277.63 Million | +14.87% |
| 2019-12-31 | €241.70 Million | +11.45% |
| 2018-12-31 | €216.88 Million | +5.24% |
| 2017-12-31 | €206.07 Million | +9.21% |
| 2016-12-31 | €188.69 Million | -13.56% |
| 2015-12-31 | €218.28 Million | +25.03% |
| 2014-12-31 | €174.59 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to U.S. Physical Therapy Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 69.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €227.26 Million | 46.48% |
| Other Components | €261.66 Million | 53.52% |
| Total Equity | €488.93 Million | 100.00% |
U.S. Physical Therapy Inc Competitors by Market Cap
The table below lists competitors of U.S. Physical Therapy Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
$960.33 Million |
|
Piramal Pharma Limited
NSE:PPLPHARMA
|
$960.51 Million |
|
PROG HOLDINGS A DL-50
F:AZD
|
$960.90 Million |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
$961.17 Million |
|
NORINCO International Cooperation Ltd
SHE:000065
|
$959.60 Million |
|
Hypoport SE
PINK:HYPOF
|
$959.41 Million |
|
Etablissementen Franz Colruyt NV
BR:COLR
|
$959.21 Million |
|
Harbin Hatou Investment Co Ltd
SHG:600864
|
$959.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in U.S. Physical Therapy Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 476,194,000 to 488,929,000, a change of 12,735,000 (2.7%).
- Net income of 26,460,000 contributed positively to equity growth.
- Dividend payments of 26,540,000 reduced retained earnings.
- Other factors increased equity by 12,815,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €26.46 Million | +5.41% |
| Dividends Paid | €26.54 Million | -5.43% |
| Other Changes | €12.81 Million | +2.62% |
| Total Change | €- | 2.67% |
Book Value vs Market Value Analysis
This analysis compares U.S. Physical Therapy Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.07x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.12x to 2.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €16.27 | €67.00 | x |
| 2018-12-31 | €17.02 | €67.00 | x |
| 2019-12-31 | €18.81 | €67.00 | x |
| 2020-12-31 | €21.49 | €67.00 | x |
| 2021-12-31 | €22.89 | €67.00 | x |
| 2022-12-31 | €24.29 | €67.00 | x |
| 2023-12-31 | €31.77 | €67.00 | x |
| 2024-12-31 | €32.39 | €67.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently U.S. Physical Therapy Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.41%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.94%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.39x
- Recent ROE (5.41%) is below the historical average (11.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 13.08% | 6.36% | 1.23x | 1.67x | €4.50 Million |
| 2015 | 12.05% | 6.30% | 1.08x | 1.78x | €3.51 Million |
| 2016 | 10.96% | 5.76% | 1.02x | 1.87x | €1.80 Million |
| 2017 | 10.86% | 5.38% | 0.99x | 2.05x | €1.77 Million |
| 2018 | 16.15% | 7.68% | 1.02x | 2.05x | €13.28 Million |
| 2019 | 16.67% | 8.31% | 0.86x | 2.33x | €16.01 Million |
| 2020 | 12.74% | 8.32% | 0.71x | 2.15x | €7.58 Million |
| 2021 | 13.81% | 8.25% | 0.66x | 2.54x | €11.27 Million |
| 2022 | 10.18% | 5.81% | 0.64x | 2.72x | €578.70K |
| 2023 | 3.08% | 2.43% | 0.61x | 2.09x | €-32.95 Million |
| 2024 | 5.41% | 3.94% | 0.58x | 2.39x | €-22.43 Million |
Industry Comparison
This section compares U.S. Physical Therapy Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| U.S. Physical Therapy Inc (UPH) | €782.44 Million | 13.08% | 0.53x | $959.81 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |